Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

121.61
Delayed Data
As of Feb 11
 +1.87 / +1.56%
Today’s Change
113.20
Today|||52-Week Range
190.29
-22.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues346.4M327.5M347.2M386.2M
 
 
 
 
 
Cost of Goods Sold6.8M12.4M7.7M2.8M
 
 
 
 
 
Depreciation And Amortization8.9M8.3M8.4M8.2M
 
 
 
 
 
 
Operating ExpensesGross Income330.6M306.7M331.1M375.2M
 
 
 
 
 
General Expenses152.0M321.6M159.4M-11.9M
 
 
 
 
 
Research And Development71.5M110.2M49.4M5.4M
 
 
 
 
 
Total Operating Expenses167.8M342.3M175.5M-858.0K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income178.6M-14.8M171.7M387.1M
 
 
 
 
 
Interest Expense On Debt3.5M2.1M1.3M834.0K
 
 
 
 
 
Other Expenses-285.0K93.0K-2.1M350.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income174.8M-16.8M168.3M736.9M
 
 
 
 
 
Income Taxes-58.8M-151.0K-69.1M-272.4M
 
 
 
 
 
Net Income115.9M-16.6M99.2M464.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS47.4M46.7M46.1M45.5M
 
 
 
 
 
Shares To Calculate EPS Diluted53.5M46.7M51.9M50.2M
 
 
 
 
 
 
Earnings Per ShareEPS$2.17-$0.36$1.91$9.24
 
 
 
 
 
EPS Diluted$2.17-$0.36$1.91$9.24